Advertisements
FDA revokes EUAs for two SARS-CoV-2 tests
kpage_drupal
Jun 27, 2022
The Food and Drug Administration today announced it has revoked the emergency use authorizations for the Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test and Simoa SARS-CoV-2 N Protein Antigen Test because no viable (non-expired) tests remain.
Headline
Advertisements